NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 53 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $36,807 | +18.6% | 44,346 | 0.0% | 0.00% | – |
| Q1 2023 | $31,042 | +190.4% | 44,346 | +111.2% | 0.00% | – |
| Q4 2022 | $10,689 | -17.8% | 21,000 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -40.9% | 21,000 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | +4.8% | 21,000 | +90.9% | 0.00% | – |
| Q1 2022 | $21,000 | +2000.0% | 11,000 | +6607.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 199,000 | $205,000 | 0.29% |
| Opaleye Management Inc. | 610,000 | $628,000 | 0.28% |
| Redmile Group, LLC | 3,436,935 | $3,540,000 | 0.14% |
| Kynam Capital Management, LP | 124,701 | $128,000 | 0.03% |
| Baker Brothers Advisors | 3,821,740 | $3,936,000 | 0.02% |
| Sio Capital Management, LLC | 38,312 | $39,000 | 0.02% |
| Candriam S.C.A. | 781,577 | $805,000 | 0.01% |
| Highland Private Wealth Management | 46,999 | $48,000 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $49,000 | 0.01% |
| Point72 Asset Management, L.P. | 1,437,417 | $1,481,000 | 0.01% |